Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

Clinical trial NCT04443348 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04443348
Sponsor: Laura M. Spring, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Hormone Receptor Positive (HR+), HER2-negative Breast Cancer Biopsy-proven, Positive Lymph Node(s)

Start date: 2020-12-16
Primary completion: 2025-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.